Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
37.72
-1.34 (-3.43%)
At close: Mar 3, 2026, 4:00 PM EST
38.20
+0.48 (1.27%)
After-hours: Mar 3, 2026, 7:18 PM EST
Soleno Therapeutics Market Cap
Soleno Therapeutics has a market cap or net worth of $1.95 billion as of March 3, 2026. Its market cap has decreased by -12.02% in one year.
Market Cap
1.95B
Enterprise Value
1.49B
1-Year Change
-12.02%
Ranking
Category
Stock Price
$37.72
Market Cap Chart
Since November 13, 2014, Soleno Therapeutics's market cap has increased from $24.70M to $1.95B, an increase of 7,783.69%. That is a compound annual growth rate of 47.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 2.02B | -18.92% |
| Dec 31, 2025 | 2.49B | 28.31% |
| Dec 31, 2024 | 1.94B | 57.88% |
| Dec 29, 2023 | 1.23B | 7,477.78% |
| Dec 30, 2022 | 16.20M | -50.46% |
| Dec 31, 2021 | 32.70M | -78.72% |
| Dec 31, 2020 | 153.70M | 17.06% |
| Dec 31, 2019 | 131.30M | 257.77% |
| Dec 31, 2018 | 36.70M | 103.89% |
| Dec 29, 2017 | 18.00M | 40.63% |
| Dec 30, 2016 | 12.80M | -44.10% |
| Dec 31, 2015 | 22.90M | 126.73% |
| Dec 31, 2014 | 10.10M | -59.11% |
| Nov 13, 2014 | 24.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ultragenyx Pharmaceutical | 2.19B |
| Ascentage Pharma Group International | 2.12B |
| Zai Lab | 2.03B |
| Celldex Therapeutics | 2.02B |
| Nuvation Bio | 1.99B |
| Syndax Pharmaceuticals | 1.94B |
| Recursion Pharmaceuticals | 1.93B |
| Nektar Therapeutics | 1.92B |